Table 2.

Clinical, histological, and genetic profile of all 19q‐loss gliomas

Case no.	Age, years	Sex	Classification	WHO grade	Side	Location	IDHmut	1p	19q	10q	p53mut	TERTmut	Oligodendroglial component	Neuropil‐like island	Adjuvant
1	29	M	AA, IDHmut	III	L	Fr	R132H	Intact	Loss	Intact	F113del	Wt	+	−	RT + TMZ
2	33	M	AA, IDHmut	III	R	Fr	R132H	Intact	Loss	Intact	G266R	Wt	+	−	RT + TMZ
3	40	M	AA, IDHmut	III	L	Fr	R132H	Intact	Loss	Intact	H179N	Wt	+	+	RT + TMZ
4	40	M	AA, IDHmut	III	R	Fr	R132H	Intact	Partial loss	Intact	R273C	Wt	+	+	RT + TMZ
5	50	M	AA, IDHmut	III	R	Fr	R132H	Intact	Loss	Intact	D49H	Wt	+	+	RT + TMZ
6	56	F	AA, IDHmut	III	R	Fr	R132H	Intact	Loss	Loss	C141Y	Wt	+	−	RT + TMZ
7	57	M	AA, IDHmut	III	L	Fr	R132H	Intact	Loss	Intact	P80 fs	Wt	+	+	PAV
8	40	M	GBM, IDHwt	IV	L	Fr	Wt	Intact	Loss	Intact	Nd	Nd	+	−	RT + TMZ
9	51	M	GBM, IDHwt	IV	L	Fr	Wt	Intact	Loss	Loss	Nd	Nd	+	−	RT + TMZ
10	52	M	GBM, IDHwt	IV	R	Fr	Wt	Intact	Loss	Loss	Nd	Nd	−	−	RT + TMZ
11	55	F	GBM, IDHwt	IV	R	P	Wt	Intact	Loss	Loss	Nd	Nd	−	−	RT + TMZ
12	58	F	GBM, IDHwt	IV	L	P	Wt	Intact	Loss	Loss	Nd	Nd	+	−	RT + TMZ
13	59	F	GBM, IDHwt	IV	R	T	Wt	Intact	Loss	Loss	Nd	Nd	−	−	RT + TMZ
14	60	M	GBM, IDHwt	IV	R	T	Wt	Intact	Loss	Intact	Nd	Nd	+	−	RT + TMZ
15	66	M	GBM, IDHwt	IV	R	Fr	Wt	Intact	Loss	Loss	Nd	Nd	+	−	RT + PAV
16	66	M	GBM, IDHwt	IV	R	Fr	Wt	Intact	Loss	Loss	Nd	Nd	+	−	RT + PAV
17	71	M	GBM, IDHwt	IV	L	P	Wt	Intact	Loss	Intact	Nd	Nd	−	−	RT + TMZ
18	76	M	GBM, IDHwt	IV	L	P	Wt	Intact	Loss	Partial loss	Nd	Nd	−	−	RT + TMZ
19	77	M	GBM, IDHwt	IV	R	Fr	Wt	Intact	Loss	Intact	Nd	Nd	+	−	RT + TMZ
20	78	M	GBM, IDHwt	IV	R	T	Wt	Intact	Loss	Loss	Nd	Nd	+	−	RT + TMZ
21	83	F	GBM, IDHwt	IV	L	P	Wt	Intact	Loss	Loss	Nd	Nd	−	−	RT + TMZ

AA, anaplastic astrocytoma; F, female; Fr, frontal lobe; GBM, glioblastoma; L, left; M, male; mut, mutant; Nd, no data; P, parietal lobe; PAV, procarbazine, ACNU, vincristine; R, right; RT, radiation therapy; T, temporal lobe; TMZ, temozolomide; Wt, wild type;